Deaths Reported to the Vaccine Adverse Event Reporting System, United States, 1997-2013

Clinical Infectious Diseases

Volumn 61, Issue 6, 2015, Pages 980-987

  Moro, Pedro L ^a   Arana, Jorge ^a   Cano, Maria ^a   Lewis, Paige ^a   Shimabukuro, Tom T ^a   Plotkin, Stanley A ^a  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

Author keywords

death; epidemiology; surveillance; vaccine safety; vaccines

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; INACTIVATED VACCINE; INFLUENZA VACCINE; PNEUMOCOCCUS VACCINE; ROTAVIRUS VACCINE; VACCINE; VARICELLA ZOSTER VACCINE;

ADOLESCENT; ADULT; AGED; ASPHYXIA; AUTOPSY; CAUSE OF DEATH; CHILD; CHILD DEATH; DEATH; DEATH CERTIFICATE; DRUG SURVEILLANCE PROGRAM; FEMALE; HUMAN; INFECTION; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MEDICAL RECORD; PARASITOSIS; PNEUMONIA; PRIORITY JOURNAL; REVIEW; SEPTICEMIA; SUDDEN INFANT DEATH SYNDROME; UNITED STATES; VACCINATION; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; INFANT; MIDDLE AGED; MORTALITY; NEWBORN; PRESCHOOL CHILD; SURVIVAL ANALYSIS; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; ADVERSE DRUG REACTION REPORTING SYSTEMS; AGED; AGED, 80 AND OVER; CAUSE OF DEATH; CHILD; CHILD, PRESCHOOL; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; SURVIVAL ANALYSIS; UNITED STATES; VACCINES; YOUNG ADULT;

EID: 84939569508     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/civ423     Document Type: Review

References (29)

1. Nakada H, Narimatsu H, Tsubokura M, et al. Risk of fatal adverse events after H1N1 influenza vaccination. Clin Infect Dis 2010; 50:1548-9.
2. McNeil MM, Broder KR, Vellozzi C, DeStefano F. Risk of fatal adverse events after H1N1 influenza vaccine: limitations of passive surveillance data. Clin Infect Dis 2010; 51:871-2.
3. Pharmaceutical and Food Safety Bureau, Ministry of Health, Labour and Welfare of Japan. Safety review results of pneumococcal conjugate vaccine and Haemophilus influenzae type b (Hib) vaccine for pediatrics, 2011. Available at: http://www.pmda.go.jp/files/000153722.pdf. Accessed 5 June 2015.
4. Pharmaceutical and Food Safety Bureau, Ministry of Health, Labour andWelfare of Japan. Pharmaceuticals and medical devices safety information No. 280, 2011. Available at: https://www.pmda.go.jp/files/000153635.pdf. Accessed 5 June 2015.
5. Global Advisory Committee on Vaccine Safety, 12-13 June 2013. Wkly Epidemiol Rec 2013; 88:301-12.
6. Institute of Medicine. Stratton KR, Howe CJ, Johnston RB Jr, eds. Adverse events associated with childhood vaccines: evidence bearing on causality. Washington, DC: National Academy Press, 1994:P274-304.
7. Silvers LE, Ellenberg SS, Wise RP, et al. The epidemiology of fatalities reported to the Vaccine Adverse Event Reporting System 1990-1997. Pharmacoepidemiol Drug Saf 2001; 10:279-85.
8. Bridges CB, Coyne-Beasley T; Advisory Committee on Immunization Practices (ACIP), ACIP Adult Immunization Work Group, Centers for Disease Control and Prevention (CDC). Advisory Committee on Immunization Practices recommended immunization schedule for adults aged 19 years or older-United States, 2014.MMWRMorb Mortal Wkly Rep 2014; 63:110-2.
9. Akinsanya-Beysolow I; Advisory Committee on Immunization Practices (ACIP); ACIP Child/Adolescent Immunization Work Group; Centers for Disease Control and Prevention (CDC). Advisory Committee on Immunization Practices recommended immunization schedules for persons aged 0 through 18 years-United States, 2014. MMWR Morb Mortal Wkly Rep 2014; 63:108-9.
10. Varricchio F, Iskander J, Destefano F, Ball R, Pless R, Braun MM. Understanding vaccine safety information from the Vaccine Adverse Event Reporting System. Pediatr Infect Dis J 2004; 23:287-94.
11. Medical Dictionary for Regulatory Activities. Available at: http://www. meddramsso.com/. Accessed 28 April 2011.
12. Food and Drug Administration. 21 CFR Part 600.80. Postmarketing reporting of adverse experiences. Vol 62: Federal Register, 1997:52252-53.
13. Hoyert DL, Xu J. Deaths: preliminary data for 2011. Natl Vital Stat Rep 2012; 61:1-51.
14. Miller E, Moro PL, Cano M, Shimabukuro TT. Deaths following vaccination: what does the evidence show? Vaccine 2015; doi:10.1016/j. vaccine.2015.05.023.
15. Woo EJ, Ball R, Braun MM. Fatal syncope-related fall after immunization. Arch Pediatr Adolesc Med 2005; 159:1083.
16. Murphy SL, Xu J, Kochanek KD. Deaths: final data for 2010. Natl Vital Stat Rep 2013; 61:1-116.
17. American Academy of Pediatrics Task Force on Sudden Infant Death Syndrome. The changing concept of sudden infant death syndrome: diagnostic coding shifts, controversies regarding the sleeping environment, and new variables to consider in reducing risk. Pediatrics 2005; 116:1245-55.
18. Brotherton JM, Hull BP, Hayen A, Gidding HF, Burgess MA. Probability of coincident vaccination in the 24 or 48 hours preceding sudden infant death syndrome death in Australia. Pediatrics 2005; 115:e643-6.
19. Centers for Disease Control and Prevention. Sudden unexpected infant death (SUID), 2011. Available at: http://www.cdc.gov/sids/. Accessed 19 August 2014.
20. Jorch G, Tapiainen T, Bonhoeffer J, et al. Unexplained sudden death, including sudden infant death syndrome (SIDS), in the first and second years of life: case definition and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine 2007; 25:5707-16.
21. Institute of Medicine. Immunization safety review: vaccinations and sudden unexpected death in infancy. Washington, DC: The National Academies Press, 2003.
22. Vennemann MM, Höffgen M, Bajanowski T, Hense HW, Mitchell EA. Do immunisations reduce the risk for SIDS? A meta-analysis. Vaccine 2007; 25:4875-9.
23. Vennemann MM, Butterfass-Bahloul T, Jorch G, et al. GeSID Group. Sudden infant death syndrome: no increased risk after immunisation. Vaccine 2007; 25:336-40.
24. Niu MT, Salive ME, Ellenberg SS. Neonatal deaths after hepatitis B vaccine: the vaccine Adverse Event Reporting System, 1991-1998. Arch Pediatr Adolesc Med 1999; 153:1279-82.
25. Eriksen EM, Perlman JA, Miller A, et al. Lack of association between hepatitis B birth immunization and neonatal death: a populationbased study from the vaccine safety datalink project. Pediatr Infect Dis J 2004; 23:656-62.
26. Hartnell NR, Wilson JP. Replication of the Weber effect using postmarketing adverse event reports voluntarily submitted to the United States Food and Drug Administration. Pharmacotherapy 2004; 24: 743-9.
27. Black S, Eskola J, Siegrist CA, et al. Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccines. Lancet 2009; 374:2115-22.
28. European Medicines Agency. No evidence that Fluad vaccine caused deaths in Italy. Available at: http://www.ema.europa.eu/ema/index.jsp? curl=pages/news-and-events/news/2014/12/news-detail-002228. jsp&mid=WC0b01ac058004d5c1. Accessed 28 May 2015.
29. McCarthy N, Weintraub E, Vellozzi C, et al. Mortality rates and causeof-death patterns in a vaccinated population. Am J Prev Med 2013; 45: 91-7.